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Background and purpose: Effective cerebral autoregulation (CA) may protect the vul-
nerable ischemic penumbra from blood pressure fluctuations and minimize neurological 
injury. We aimed to measure dynamic CA within 6 h of ischemic stroke (IS) symptoms 
onset and to evaluate the relationship between CA, stroke volume, and neurological 
outcome.
Methods: We enrolled 30 patients with acute middle cerebral artery IS. Within 6 h of 
IS, we measured for 10  min arterial blood pressure (Finometer), cerebral blood flow 
velocity (transcranial Doppler), and end-tidal-CO2. Transfer function analysis (coherence, 
phase, and gain) assessed dynamic CA, and receiver-operating curves calculated rele-
vant cut-off values. National Institute of Health Stroke Scale was measured at baseline. 
Computed tomography at 24 h evaluated infarct volume. Modified Rankin Scale (MRS) 
at 3 months evaluated the outcome.
results: The odds of being independent at 3 months (MRS 0–2) was 14-fold higher when 
6 h CA was intact (Phase > 37°) (adjusted OR = 14.0 (IC 95% 1.7–74.0), p = 0.013). 
Similarly, infarct volume was significantly smaller with intact CA [median (range) 1.1 
(0.2–7.0) vs 13.1 (1.3–110.5) ml, p = 0.002].
conclusion: In this pilot study, early effective CA was associated with better neurological 
outcome in patients with IS. Dynamic CA may carry significant prognostic implications.
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inTrODUcTiOn
Reperfusion and neuroprotection are the current mainstays of acute ischemic stroke (IS) manage-
ment. In this regard, arterial blood pressure (ABP) management may play a central role to maintain 
optimal perfusion within the vulnerable ischemic penumbra (1, 2). Unfortunately, several clinical 
trials in ABP modulation had no effect on prognosis (2) and, therefore, the corresponding current 
guidelines remain evasive (3). Perhaps, the crucial factor is not ABP per se, but rather how cerebral 
TaBle 2 | cerebral autoregulation and outcome at 3 months.
Total independency
Yes no
N = 30 N = 17 N = 13
Heart rate, bpm 70 ± 11 70 ± 10 71 ± 12
Systolic ABP, mmHg 136 ± 23 134 ± 20 138 ± 23
Mean ABP, mmHg 81 ± 14 84 ± 15 77 ± 17
Diastolic ABP, mmHg 54 ± 13 57 ± 13 50 ± 17
EtCO2, mmHg 37 ± 6 36 ± 5 37 ± 5
Cerebral hemodynamics
Infarct hemisphere
MFV, cm/s 42 ± 15 46 ± 18 49 ± 13
Coherence, a.u. 0.5 ± 0.2 0.5 ± 0.2 0.5 ± 0.2
Gain,%/mmHg 1.0 ± 0.4 0.8 ± 0.2 *1.1 ± 0.5
Phase, degrees 36 ± 38 50 ± 25 *21 ± 47
Non-infarct hemisphere
MFV, cm/s 50 ± 16 50 ± 17 46 ± 12
Coherence, a.u. 0.5 ± 0.2 0.5 ± 0.2 0.6 ± 0.2
Gain,%/mmHg 1.1 ± 0.6 0.9 ± 0.2 1.1 ± 0.6
Phase, degrees 43 ± 33 48 ± 21 39 ± 40
Interhemispheric = ipsilateral-minus-contralateral values; MFV, mean flow velocity; ABP, 
arterial blood pressure; EtCO2, end-tidal carbon dioxide; a.u., arbitrary units.
*P < 0.05 significance value of Mann–Whitney. Values in mean ± SD.
TaBle 1 | Patients characteristics according to outcome at 3 months.
Total independency
Yes no
N = 30 N = 17 N = 13
Gender male, n (%) 16 (53) 9 (53) 5 (39)
Age, years (mean ± SD) 69 ± 13 63 ± 13 76 ± 9*
BMI, kg m−2 (mean ± SD) 26.9 ± 5.5 26.9 ± 4.0 26.9 ± 7.0
Atrial fibrillation, n (%) 11 (37) 4 (23) 7 (55)
Hypertension, n (%) 20 (67) 9 (53) 11 (85)
Diabetes mellitus, n (%) 12 (40) 4 (25) 8 (60)
Dyslipidemia, n (%) 22 (74) 12 (71) 10 (76)
Tobacco, n (%) 5 (17) 3 (18) 2 (15)
Large vessel atherosclerosis 4 (13) 2 (10) 2 (20)
Cardioembolic 11 (37) 4 (20) 7 (60)
Small vessel disease, n (%) 3 (10) 1 (1) 2 (5)
Undetermined, n (%) 8 (27) 2 (10) 6 (55)
Thrombolysis, n (%) 20 (67) 11 (55) 9 (53)
Baseline NIHSS, median (IQR) 9 (5–15) 6 (4–13) 12 (8–20)*
BMI, body-mass index; NIHSS, National Institutes of Health Stroke Scale.
*P < 0.05 significance value of Mann–Whitney. Values in mean ± SD.
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blood flow can adapt to pressure changes and/or demand, i.e., 
cerebral autoregulation (CA) (4).
Dynamic CA (dCA) can be assessed using transfer function 
analysis (TFA) between spontaneous oscillations of ABP and 
cerebral blood flow velocity (CBFV) (4). CA has been studied in 
acute stroke (5) with conflicting results (5–8), but the early hours, 
where penumbra is more vulnerable, has been largely ignored.
Therefore, we aimed to assess dCA within 6 h of IS symptoms 
and its relationship with final infarct volume and 90-day func-
tional outcome.
MaTerials anD MeThODs
study Population
São João Hospital center ethical committee approved the study. 
Written informed consent was obtained. We included consecu-
tive patients with middle cerebral artery (MCA) territory acute 
IS, admitted to our stroke unit. Ultrasound studies (Vivid e; GE) 
excluded hemodynamically significant extra- or intracranial 
stenoses. Patients with MCA proximal occlusion were excluded, 
as it prevented monitoring.
Monitoring and Data analysis
Evaluations were carried out at stroke unit in supine position. We 
monitored for 10 min CBFV with transcranial Doppler M1-MCA 
(BoxX-DWL, Germany), ABP with Finometer MIDI (FMS, 
Netherlands), heart-rate and end-tidal carbon dioxide (EtCO2) 
with capnograph (Respsense/Nonin, Netherlands). Systolic, 
diastolic, and mean values of ABP (MBP) and of CBFV (MFV) 
were calculated (4). TFA assessed dCA by calculating coherence, 
gain, and phase parameters from beat-to-beat MFV and MBP 
spontaneous oscillations in low frequency range (0.03–0.15 Hz) 
(4) as previously detailed (9).
Outcomes and statistics
Baseline National Institutes of Health Stroke Scale (NIHSS) 
scores were calculated. Independence, modified Rankin Scale 
(0–2), at 90 days determined the outcome by a stroke physician 
blinded for the initial assessment. Head CT (Siemens Somaton/
Emotion Duo, Germany) at 24 h measured infarct volume with 
ABC/2 formula.
Shapiro–Wilk test determined normality. Mann–Whitney 
and χ2 tests compared hemodynamic measurements between 
subgroups. ROC analysis found relevant cutoff values. After 
dichotomization, multivariate logistic regression calculated the 
odds ratio. Relationship between continuous variables was deter-
mined by Spearman’s correlation and adjusted with multivariate 
linear regression models. Level of significance was p < 0.05.
resUlTs
We recruited 30 patients characterized in Table 1. The relationship 
between dCA and outcome is presented in Table 2. Independence 
at 3 months was associated with higher phase (p =  0.024) and 
lower gain (p =  0.045) in the stroke hemisphere within 6  h of 
onset. ROC curve analysis found best cutoffs, associated with 
independency, in phase at 37° (affected side, AUC  =  0.713, 
p  =  0.028; sensitivity 70%, specificity 79%) but gain under-
performed (AUC =  0.654, p =  0.112). Based on these cutoffs, 
independency at 3  months (Figure  1A) could be predicted by 
phase level in the affected side [phase ≥ 37°, adjusted OR = 14.0 
(IC 95% 1.7–74.0), p = 0.013] when adjusted to baseline NIHSS 
and age. Additionally, lower infarct volumes at 24 h (Figure 1C) 
were measured in subgroups of higher phase in the affected side 
[median (range) 1.1 (0.2–7.0) vs 13.1 (1.3–110.5) ml, p = 0.002]. 
Low and high phase subgroups were also not significantly differ-
ent in baseline NIHSS (Figure 1B, p = 0.062). When phase was 
FigUre 1 | independency at 3 months (a), baseline national institutes of health stroke scale score (B) and infarct volume (c) accordingly subgroups 
of worse (phase < 37°) and better (phase ≥ 37°) dynamic ca (dca) on the ischemic hemisphere. Bars represent % and box-and-whiskers plots medians/
interquartile ranges. Significant results (p < 0.05) are topped by asterisks. (D) Scatter plot showing infarct volumes at 24 h (ml) plotted against baseline systolic 
arterial blood pressure level separated by subgroups of worse (phase <37°, black dots) and better (phase ≥37°, gray dots) dCA, and respective linear regression 
lines and 95% confidence interval.
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analyzed as a continuous variable, it correlated with stroke volume 
in the affected side (r = −0.444, p = 0.020) but not contralateral 
(r = −0.125, p = 0.409). In multivariate linear regression, only 
NIHSS significantly predicted infarct volume at 24 h (p = 0.002) 
but not phase (p =  0.457). Baseline systolic ABP was inversely 
correlated with infarct volume at 24 h (r = −0.665, p = 0.008) 
but only in the subgroup with lower phase in the infarct side 
(Figure 1D).
DiscUssiOn
We showed that the efficacy of dCA during the first 6  h after 
symptom onset is associated with smaller infarct volumes at 24 h 
and better neurological outcome at 3 months.
Transfer function analysis of the spontaneous ABP and 
CBFV oscillations is increasingly used to assess dCA in a 
number of neurovascular disorders (7–10). The phase of this 
relationship, which represents the time delay between these 
oscillating waveforms, has emerged as a significant predictor of 
outcome. Lower phase shift (ineffective CA) has been linked to 
carotids or MCA stenosis (11) or development of vasospasm 
after subarachnoid hemorrhage (10). In patients with IS, phase 
has also been linked to stroke severity (5, 7). The impaired CA 
can be also related to patient medical conditions not addressed 
in this study. For example, impaired cerebral autoregulation in 
patients with sleep apnea has been linked to an increased risk 
of stroke (12). Our findings, which build on these prior stud-
ies, show that effective dCA, as demonstrated by higher phase 
shift, is linked to smaller stroke volumes and better neurological 
outcome. Moreover, consistent with prior work where a phase 
>30 represents effective or intact autoregulation (4, 5, 9), we 
also found a cutoff value of 37° for phase that was predictive 
of neurological independence at 3 months and smaller stroke 
volumes at 24 h.
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Interestingly, we also found that a lower systolic ABP is 
associated with larger infarcts but only if CA is impaired in the 
infarct side (phase <37°). This observation enhances the biologi-
cal plausibility of the link between phase (dCA), stroke volume 
and clinical outcome, since lower ABP would only endanger 
the ischemic penumbra with further hypoperfusion if CA was 
impaired. Taken together, CA assessment could, therefore, iden-
tify patients who would benefit from BP augmentation in future 
clinical trials (13) Perfusion imaging, instead of CA assessment, 
may have been more helpful to explain larger infarcts at 24 h by 
estimation of initial penumbra area. However, an impaired CA at 
baseline could itself be responsible for this larger penumbra. The 
question remains to be answered in future studies with correlative 
measurements with perfusion scanning.
In line with prior studies (5), gain seems not to be a good 
marker for stroke outcome. Nevertheless, lower gain values (more 
effective CA) on the stroke side seemed to be associated with 
independence at 3 months.
This study has some limitations. As it is a pilot study, we enrolled 
a small number of subjects. Regarding the TCD method, there 
are limitations inherent to CA assessment with TCD (4), as some 
non-stationary conditions (e.g., agitation, mental changes) might 
turn linear methods like TFA less reliable. Also, M1 occlusions 
could not be assessed. As CA was assessed after IV thrombolysis 
within 6  h of symptoms, non-occluded M1 cases in this study 
include recanalyzed MCA or branch occlusions while those who 
were excluded due to M1 occlusion are mostly non-recanalized 
MCA. Having said that, we still can see this as a limitation but 
occluded M1 after IV thrombolysis is itself a maker for very bad 
prognosis and we believed that CA assessment would not add any 
significant contribution in this scenario; we also monitored this 
excluded cases and only 1/16 (6%) was independent at 3 months 
and all had total MCA area involvement. So, what our study 
points out is that even if we recanalyze the MCA artery <6h, those 
with better CA (phase ≥37°) will have higher chance of being 
independent at 3 months.
Concerning the infarct volume, we used CT scan, which is not 
as reliable as MRI. However, most of the stroke patients had easily 
identifiable partial or total areas of MCA infarct. Although CT 
scan is a coarse measure, we believe that the overall results were 
not influenced by this method.
 1. In summary, we showed that the efficacy of dCA in the early 
hours of IS is linked to infarct volume at 24 h and neurological 
outcome at 3 months. Rapid bedside assessment of CA may 
help to identify a high risk population with impaired CA who 
would benefit from different BP management.
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